COMP <GO>
WRBY vs MRK // PIOTROSKI F-SCORE QUALITY
Warby Parker Inc. (NYSE) VS. Merck & Company Inc. Common Stock (new) (NYSE) • 15-METRIC TALLY: WRBY 4
— MRK 10
▲ PIOTROSKI F-SCORE QUALITY LEADER: WRBY
LAST: $24.61 (+0.08%) • MKT CAP: $3.04B
piotroski-score
9/9
LAST: $149.52 (+2.18%) • MKT CAP: $361.02B
piotroski-score
7/9
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (WRBY VS. MRK)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | WRBY | MRK | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 54.00% | 74.80% | -20.80 | MRK | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -1.70% | 20.70% | -22.40 | MRK | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 15.3x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 1.44% | 3.42% | -1.98 | MRK | /fcf-yield <GO> |
| Operating Margin | -0.60% | 34.30% | -34.90 | MRK | /operating-margins <GO> |
| Net Profit Margin | 0.20% | 28.10% | -27.90 | MRK | /net-margins <GO> |
| Revenue Growth (YoY) | 13.00% | 1.30% | +11.70 | WRBY | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.26% | -2.26 | MRK | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 5.35 | 5.19 | +0.16 | WRBY | /balance-sheet <GO> |
| Piotroski F-Score Quality ACTIVE | 9/9 | 7/9 | +2.00 | WRBY | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 7.40% | 6.60% | +0.80 | MRK | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 45.9 | 56.9 | -10.93 | MRK | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.14 | 0.92 | +0.22 | WRBY | /macro-sensitivity <GO> |
| Forward P/E Multiple | 140.0x | 18.4x | +121.60 | MRK | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $3.04B | $361.02B | -$357.98B | MRK | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | WRBY REV | MRK REV | WRBY GROSS % | MRK GROSS % | WRBY FCF | MRK FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $871.9M | $65.01B | 54.0% | 74.8% | $43.7M | $12.36B |
| FY 2024 | $771.3M | $64.17B | 55.3% | 76.3% | $34.7M | $18.10B |
| FY 2023 | $669.8M | $60.12B | 44.0% | 44.0% | $30.9M | $10.30B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
WRBY // BETA 1.14
MRK // BETA 0.92